Cargando…

Influence of insulin resistance on the development of hepatocellular carcinoma after antiviral treatment for non-cirrhotic patients with chronic hepatitis C

BACKGROUND: Insulin resistance is considered to be an important factor in the progression of fibrosis and the enhancement of the risk of hepatocellular carcinoma (HCC) for chronic hepatitis C patients. The aim of this study was to assess the effect of insulin resistance on the development of HCC by...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hayashi, Takeo, Ogawa, Eiichi, Furusyo, Norihiro, Murata, Masayuki, Hayashi, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4765113/ https://www.ncbi.nlm.nih.gov/pubmed/26913058 http://dx.doi.org/10.1186/s13027-016-0056-y

Ejemplares similares

Treatment for Eradication of Helicobacter pylori Infection among Chronic Hepatitis C Patients
por: Furusyo, Norihiro, et al.
Publicado: (2011)

Development of Hepatocellular Carcinoma in Patients Aged 75–84 Years With Chronic Hepatitis C Treated With Direct-Acting Antivirals
por: Ogawa, Eiichi, et al.
Publicado: (2020)

Tenofovir alafenamide in the treatment of chronic hepatitis B: design, development, and place in therapy
por: Ogawa, Eiichi, et al.
Publicado: (2017)

Secondary Syphilis with Pulmonary Involvement
por: Ohta, Azusa, et al.
Publicado: (2017)

Long‐term assessment of recurrence of hepatocellular carcinoma in patients with chronic hepatitis C after viral cure by direct‐acting antivirals
por: Ogawa, Eiichi, et al.
Publicado: (2021)

A case of granulomatosis with polyangiitis preceded by subacute thyroiditis
por: Mukae, Haru, et al.
Publicado: (2015)

Excellent superiority and specificity of COBAS TaqMan HCV assay in an early viral kinetic change during pegylated interferon alpha-2b plus ribavirin treatment
por: Ogawa, Eiichi, et al.
Publicado: (2010)

Toxocariasis Suspected of Having Infiltrated Directly from the Liver to the Lung through the Diaphragm
por: Kakimoto, Masaki, et al.
Publicado: (2019)

A case report of human immunodeficiency virus-associated anaplastic lymphoma kinase protein-negative anaplastic large cell lymphoma
por: Taniai, Hiroaki, et al.
Publicado: (2013)

Incidence of Hepatocellular Carcinoma after Treatment with Sofosbuvir-Based or Sofosbuvir-Free Regimens in Patients with Chronic Hepatitis C
por: Ogawa, Eiichi, et al.
Publicado: (2020)

Systematic review and meta-analysis: real-world effectiveness of direct-acting antiviral therapies in chronic hepatitis C genotype 3 in Asia
por: Wei, Bin, et al.
Publicado: (2018)

HIV infection with concomitant cerebral toxoplasmosis and disseminated histoplasmosis in a 45-year-old man
por: Murata, Masayuki, et al.
Publicado: (2007)

De novo hepatocellular carcinoma occurrence in hepatitis C cirrhotics treated with direct-acting antiviral agents
por: Kuftinec, Gabriela, et al.
Publicado: (2018)

Revised Korean Antiviral Guideline Reduces the Hepatitis B-related Hepatocellular Carcinoma Risk in Cirrhotic Patients
por: Kim, David Sooik, et al.
Publicado: (2021)

The Relation between Serum Endostatin Level and Carotid Atherosclerosis in Healthy Residents of Japan: Results from the Kyushu and Okinawa Population Study (KOPS)
por: Kato, Yoshifumi, et al.
Publicado: (2017)

Non-cirrhotic hepatocellular carcinoma in chronic viral hepatitis: Current insights and advancements
por: Perisetti, Abhilash, et al.
Publicado: (2021)

Deveopment of hepatocellular carcinoma in a non-cirrhotic, long-term responder to antiviral therapy, chronic hepatitis C patient: what kind of surveillance?
por: Bertolini, Elena, et al.
Publicado: (2013)

Correlation between Thyroid Stimulating Hormone and Renal Function in Euthyroid Residents of Japan: Results from the Kyushu and Okinawa Population Study (KOPS)
por: Tanaka, Yuki, et al.
Publicado: (2018)

Improved on-treatment fibrosis-4 during antiviral therapy and lower hepatocellular carcinoma risk in cirrhotic patients with hepatitis B
por: Oh, Joo Hyun, et al.
Publicado: (2023)

Changing Trends of Cirrhotic and Noncirrhotic Hepatocellular Carcinoma in the Era of Directly-Acting Antiviral Agents
por: Mathur, Karan, et al.
Publicado: (2021)

Kyushu and Okinawa Population Study (KOPS): a large prospective cohort study in Japan
por: Ikezaki, Hiroaki, et al.
Publicado: (2021)

Direct-acting antivirals for hepatitis C virus-infected patients with hepatocellular carcinoma
por: Tajiri, Kazuto, et al.
Publicado: (2022)

Effects of lamivudine on serum albumin levels correlate with pretreatment HBV-DNA levels in cirrhotic patients
por: Nakamuta, Makoto, et al.
Publicado: (2007)

Small Dense Low-Density Lipoprotein Cholesterol and Carotid Intimal Medial Thickness Progression
por: Ikezaki, Hiroaki, et al.
Publicado: (2020)

Cost-effectiveness analysis of sofosbuvir plus ribavirin in patients with genotype 2 chronic hepatitis C: an analysis with real world outcomes from a multicentre cohort in Japan
por: Igarashi, Ataru, et al.
Publicado: (2019)

Non-invasive imaging criteria for the diagnosis of hepatocellular carcinoma in non-cirrhotic patients with chronic hepatitis B
por: Moctezuma-Velázquez, Carlos, et al.
Publicado: (2021)

Clinicopathological and prognostic significance of PKM2 protein expression in cirrhotic hepatocellular carcinoma and non-cirrhotic hepatocellular carcinoma
por: Liu, Yan, et al.
Publicado: (2017)

Morbidity and Mortality After Major Hepatic Resection in Cirrhotic Patients With Hepatocellular Carcinoma
por: Nagasue, Naofumi, et al.
Publicado: (1988)

ICG Clearance in Assessing Cirrhotic Patients with Hepatocellular Carcinoma for Major Hepatic Resection
por: Kitano, Seigo, et al.
Publicado: (1997)

Association of the Serum Endostatin Level, Renal Function, and Carotid Atherosclerosis of Healthy Residents of Japan: Results from the Kyushu and Okinawa Population Study (KOPS)
por: Kato, Yoshifumi, et al.
Publicado: (2018)

Hepatocellular Carcinoma Arising in Non-Cirrhotic Haemochromatosis
por: Thompson, N. P., et al.
Publicado: (1995)

Segmental Distribution of Hepatocellular Carcinoma in Cirrhotic Livers
por: Renzulli, Matteo, et al.
Publicado: (2022)

Competing risk analysis on outcome after hepatic resection of hepatocellular carcinoma in cirrhotic patients
por: Cucchetti, Alessandro, et al.
Publicado: (2017)

Real-world effectiveness of sofosbuvir plus ribavirin for chronic hepatitis C genotype 2 in Asia: a systematic review and meta-analysis
por: Wei, Bin, et al.
Publicado: (2018)

An unfortunate failure: multifocal hepatocellular carcinoma in a non-cirrhotic patient with chronic hepatitis C treated with ledipasvir/sofosbuvir
por: Soliman, Megan Sue, et al.
Publicado: (2018)

Clinical cure and liver fibrosis reversal after postoperative antiviral combination therapy in hepatitis B-associated non-cirrhotic hepatocellular carcinoma: A case report
por: Yu, Xue-Ping, et al.
Publicado: (2021)

The hurdle with remaining risk for hepatocellular carcinoma in cirrhotic patients after a hepatitis C cure
por: Aleman, Soo
Publicado: (2016)

Analysis of Hepatic Fibrosis Characteristics in Cirrhotic Patients with and without Hepatocellular Carcinoma by FTIR Spectral Imaging
por: Moreau, Johanna, et al.
Publicado: (2020)

Inflammatory patterns in plasma associate with hepatocellular carcinoma development in cured hepatitis C cirrhotic patients
por: Owusu Sekyere, Solomon, et al.
Publicado: (2021)

Investigation of the Effect of KIR–HLA Pairs on Hepatocellular Carcinoma in Hepatitis C Virus Cirrhotic Patients
por: Umemura, Takeji, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sgd3i9do2djbuce4hv5cuufer6